Olorofim Aspergillus Infection Study

Condition:   Invasive Aspergillosis Interventions:   Drug: Olorofim;   Drug: AmBisome® Sponsors:   F2G Biotech GmbH;   Iqvia Pty Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials